In AD pathology, low PACAP levels have been observed in cerebrospinal fluid (CSF) samples and the brain tissue of human patients, which correlated with cognitive decline during mild cognitive impairment and dementia stages [180]. Here, ADCYAP1 is linked to Alzheimer disease.